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Background: Observational epidemiologic data suggest
that transmission of viral respiratory infection was signif-
icantly reduced during the SARS epidemic with the use of
face masks as well as other infection control measures. How-
ever, there are no prospective randomised control trials on
face masks in prevention of viral respiratory infections Aims:
To determine the efﬁcacy of surgical masks and P2 masks in
households on the interruption of transmission of respiratory
viruses.
Methods: Prospective cluster randomized trial comparing
surgical masks, non-ﬁt-tested P2 (respirator) masks with no
masks in interruption of viral transmission between house-
hold members. Families of children presenting to emergency
department with inﬂuenza like illness (ILI) were randomised
to one of the three groups and followed up for devel-
opment of respiratory illness in other family members.
Nasopharyngeal swabs of index patients and contacts that
developed ILI were tested with a multiplex respiratory viral
PCR for inﬂuenza A and B, parainﬂuenza, RSV, picornavirus,
enterovirus, rhinovirus, adenovirus, coronaviruses human
metapneumovirus.
Results: We recruited 286 adults with exposure to respi-
ratory infections in the Australian winters of 2006 and 2007 -
94 adults were randomized to surgical masks, 90 to P2 masks
and 102 to the control group. Using intention to treat analy-
sis, we found no signiﬁcant difference in the relative risk of
respiratory illness in the mask groups compared to control
group. However, compliance with mask use was less than
50%. In an adjusted analysis of compliant subjects, masks as
a group had protective efﬁcacy in excess of 80% against clin-
ical inﬂuenza-like illness. The efﬁcacy against proven viral
infection and between P2 masks (57%) and surgical masks
(33%) was non-signiﬁcant.
Conclusions: This is the ﬁrst RCT on mask use to be con-
ducted and provides data to inform pandemic planning. We
found compliance to be low, but compliance is affected by
perception of risk. In a pandemic, we would expect com-
pliance to improve. In compliant users, masks were highly
efﬁcacious. A larger study is required to enumerate the dif-
ference in efﬁcacy (if any) between surgical and non-ﬁt
tested P2 masks.
doi:10.1016/j.ijid.2008.05.877
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Introduction: Since February/March 2005, Chikungunya
has been an emerging infection in the Indian Ocean. We
report an observational study to describe the complications
post-Chikungunya in a sample of affected people in Mauri-
tius.
Methods: Ethical clearance was obtained for this study.
Data collection was carried out in February and March 2007
on a random sample of people who had suffered from
Chikungunya in 2005 and 2006. Data was collected by means
of a comprehensive questionnaire.
Results: Participants comprised 77 people of whom 41
were males and 36 were females. Participants ranged from
6 to 69 years. It was found that 70 of the participants expe-
rienced persisting joint pains for at least 6 months following
the acute phase. 35 of these participants had residual joint
complaints after 6 months. 44 of all participants suffered
from psychological sequelae out of which 37 complained of
pessimism, 35 of lack of concentration, 31 of insomnia, 31
of depression, 22 of aggressiveness, and 17 of confusion. 10
participants had dermatological sequelae which consisted of
increased pigmentation on the face or on limb extremities,
6 had iatrogenic complications due to NSAIDS induced gastri-
tis, and 3 participants with serologically proven Chikungunya
had neurological manifestations and changes on CT/MRI
which could correspond to demyelination. Complications
increased with age. From July 2005 till June 2006, there
was a signiﬁcant increase in the number of deaths which
could be Chikungunya related. Statistical analysis demon-
strated that there was a signiﬁcant difference in the number
of complications according to gender, females being more
affected than males and also in those participants with co-
morbidity being more affected than others. Psychological
sequelae were found to be dependent on co-morbidity.
Discussion and conclusion: Though this study had lim-
itations such as a small sample size and the data relied
mostly on clinical diagnosis, results yield useful information
on complications of Chikungunya. This study highlights that
Chikungunya which causes a signiﬁcant impact on health in
the acute phase can have signiﬁcant sequelae months after-
wards and this includes psychological sequelae. More studies
need to be carried out to conﬁrm these preliminary ﬁndings.
doi:10.1016/j.ijid.2008.05.878
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Background: Dengue virus (DEN-V) infection has become
one of the major public health problems in many tropical
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and subtropical areas. The ﬁrst documented appearance of
DEN-V infection in Kingdom of Saudi Arabia was in Jeddah,
western region in 1994, and the infection is still endemic
in the area. The aim of this study was to determine the
presence and typing of DEN-Vs in hospitalized patients in
western region of Saudi Arabia.
Materials and Methods: Three hundred and ﬁve serum
samples from suspected inpatients were collected during
April to August 2007 and were screened for dengue viruses.
The samples were cultured on C6/36 mosquito cell line
to determine the cytopathic effects and to identify the 4-
serotypes of DEN-Vs using indirect immunoﬂuorescent assay
(IFA). IgM/IgG ELISA assays were also used to detect the inci-
dence of infection. In addition, RT-nested-PCR was used to
detect and identify the types of dengue viruses.
Results: ELISA screening showed that 32(10.5%) samples
were positive for DEN-V IgM, 74(24.2%) were positive for
DEN-V IgG and 56(18.4%) were positive for both IgM and IgG.
IFA revealed 40(13.1%) positive cases of DEN-V, of them:
8(20%) DEN-V1, 7(17.5%) DEN-V2, and 25(62.5%) samples
DEN-V3. The RT-PCR showed that 89(29.2%) samples were
positive for DEN-V, of them 16(17.9%) samples were positive
for DEN-V1, 20(22.5%) DEN-V2 and 53(59.6%) DEN-V3. DEN-
V4 was not detected by RT-PCR and IFA. The seroprevalence
was 162(53.1%), while the incidence was 39(24.1%).
Conclusion: This study showed a high seroprevalence and
low incidence of dengue virus infection in the study popula-
tion. Approximately half of the patients were at a high risk
of developing dengue hemorrhagic fever and dengue shock
syndrome at subsequent infection. Because of its high sen-
sitivity and speciﬁcity, we recommend the use of RT-PCR
for rapid direct diagnosis and typing of dengue viruses in
addition to the conventional methods.
doi:10.1016/j.ijid.2008.05.879
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Background: Réunion Island Chikungunya outbreak begun
on April 2005 and was maximal during the ﬁrst 2006 quar-
ter. For the ﬁrst time a mother to child transmission was
described, viral genome was found in the amniotic liquid,
plasma and cerebrospinal ﬂuid of some fetus and new-born.
We do not know if Chikungunya infection during pregnancy
may cause fetal loss, premature delivery, small for age new-
born or neonatal mortality. Our aim was to study the effect
of Chikungunya outbreak on pregnancy length, new-born
weight, fetal loss and perinatal mortality.
Methods: Data for the 2004—2006 period come from
social and health administrations of Réunion Island witch
collect information about almost each pregnancy and deliv-
ery. During the study period la Caisse d’Allocation Familiale
(Family Allowance Ofﬁce) had registered 41,665 deliveries
with information on fetal loss, still birth and neonatal mor-
tality and la Protection Maternelle et Infantile (Mother and
Child Welfare) 42,359 alive new-born with information on
term, and weight. Deliveries of 2006 ﬁrst quarter were com-
pared to the 2004—2005 ﬁrst quarter.
Results: Abortion and fetal loss before 22 weeks of
pregnancy were not different for the ﬁrst quarter of 2006
compared to 2005 and 2004 (1.1 versus 1.2%). Perinatal mor-
tality (fetal loss after 22 weeks, still-birth and neonatal
mortality before 28 days) was not different for the ﬁrst quar-
ter of 2006 compared to 2005 and 2004 (1.8 versus 1.3%).
Percentage of delivery before 37 weeks was similar for ﬁrst
quarter deliveries of 2006 compared to 2005 and 2004 (9.1
versus 10.1%). Percentage of small-for-age (<10◦p) new-born
was similar for ﬁrst quarter of 2006 compared to 2005 and
2004 (10.5 versus 10.0%).
Conclusion: We do not identify any increased risk of fetal
loss before 22 weeks of pregnancy, perinatal mortality, pre-
mature delivery, small-for-age new-born between January
and March 2006.
doi:10.1016/j.ijid.2008.05.880
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Objectives: The genus Erwinia consists of 12 validated
species which are associated with plants as pathogens, but,
clinical isolates are exceedingly rare; only one species,
Erwinia persicina, has been isolated from the urine of a
woman with a urinary tract infection. Erwinia tasmaniensis
is a recently describe species. It was isolated from ﬂow-
ers and barks of apple and pear trees in Australia, but was
not pathogenic on plants. We presently describe the isola-
tion of a bacterium from the excisional tissue of a patient
with cervical lymphadenitis that was determined to be an
E. tasmaniensis-like organism.
Results: A 79-year-old woman visited a hospital for eval-
uation of left side cervical lymphadenopathy and headache
that had begun three days previously. On physical exam-
ination, her left neck had multiple, 0.5—1.5 cm sized,
tender, conglomerated lymph nodes, but other ﬁndings were
unremarkable. Neck sonography showed multifocal necrotic
lymph node in the left side of the neck with perinodal
inﬁltration. An excisional biopsy was performed. Pathologic
examination revealed central necrosis with peripheral hem-
orrhages, with no evidence of malignancy or tuberculosis.
Culture of tissue obtained from the biopsy isolated a bac-
terium that was identiﬁed as Pantoea sp. by VITEK 2 in the
clinical microbiology laboratory. For more precise identiﬁca-
tion, 16S rRNA gene analysis was undertaken. A 1,289 bp of
the 16S rRNA gene was obtained from the bacterium, which
was designated ABB-Jeju-1. The determined 16S rRNA gene
